News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
268,897 Results
Type
Article (14407)
Company Profile (281)
Press Release (254209)
Multimedia
Podcasts (48)
Webinars (7)
Section
Business (79743)
Career Advice (154)
Deals (13284)
Drug Delivery (35)
Drug Development (50971)
Employer Resources (31)
FDA (5748)
Job Trends (5192)
News (145188)
Policy (10098)
Tag
2024 BioCapital Digital (6)
2024 BioForest Digital (1)
2024 BioMidwest Digital (4)
2024 Bio NC Digital (4)
2024 Biotech Bay Standard (10)
2024 Biotech Beach Digital (5)
2024 Biotech Beach Standard (3)
2024 Genetown Digital (7)
2024 Genetown Standard (6)
2024 Lone Star Bio Digital (4)
2024 Pharm Country Digital (4)
2024 Pharm Country Standard (3)
2025 BioForest Digital (3)
2025 Lone Star Bio Digital (3)
2026 BioMidwest Elite (1)
2026 Bio NC Standard (1)
2026 Biotech Bay Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Genetown Standard (1)
2026 Pharm Country Elite (1)
2026 Pharm Country Standard (1)
Academia (940)
Accelerated approval (2)
Adcomms (12)
Allergies (51)
Alliances (21718)
ALS (67)
Alzheimer's disease (847)
Antibody-drug conjugate (ADC) (89)
Approvals (5772)
Artificial intelligence (119)
Autoimmune disease (17)
Automation (5)
Bankruptcy (105)
Best Places to Work (4618)
BIOSECURE Act (5)
Biosimilars (42)
Biotechnology (232)
Bladder cancer (47)
Brain cancer (20)
Breast cancer (146)
Cancer (1379)
Cardiovascular disease (116)
Career advice (134)
Career pathing (2)
CAR-T (112)
Cell therapy (319)
Cervical cancer (8)
Clinical research (41364)
Collaboration (522)
Compensation (260)
Complete response letters (13)
COVID-19 (1056)
CRISPR (39)
C-suite (154)
Cystic fibrosis (76)
Data (1437)
Denatured (11)
Depression (29)
Diabetes (131)
Diagnostics (1296)
Digital health (3)
Diversity (2)
Diversity, equity & inclusion (9)
Drug discovery (83)
Drug pricing (28)
Drug shortages (3)
Duchenne muscular dystrophy (88)
Earnings (29838)
Editorial (18)
Employer branding (4)
Employer resources (29)
Events (48636)
Executive appointments (441)
FDA (6422)
Featured Employer (30)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (486)
Gene editing (93)
Generative AI (10)
Gene therapy (240)
GLP-1 (365)
Government (1088)
Grass and pollen (2)
Guidances (19)
Healthcare (6637)
Huntington's disease (22)
IgA nephropathy (22)
Immunology and inflammation (89)
Indications (19)
Infectious disease (1121)
Inflammatory bowel disease (113)
Inflation Reduction Act (8)
Influenza (19)
Intellectual property (62)
Interviews (17)
IPO (7308)
IRA (11)
Job creations (862)
Job search strategy (128)
Kidney cancer (6)
Labor market (5)
Layoffs (207)
Leadership (3)
Legal (1391)
Liver cancer (31)
Lung cancer (197)
Lymphoma (92)
Machine learning (2)
Management (7)
Manufacturing (126)
MASH (50)
Medical device (2607)
Medtech (2608)
Mergers & acquisitions (6296)
Metabolic disorders (377)
Multiple sclerosis (53)
NASH (13)
Neurodegenerative disease (65)
Neuropsychiatric disorders (23)
Neuroscience (1244)
NextGen: Class of 2025 (2025)
Non-profit (855)
Northern California (1634)
Now hiring (22)
Obesity (191)
Opinion (102)
Ovarian cancer (61)
Pain (41)
Pancreatic cancer (53)
Parkinson's disease (119)
Partnered (8)
Patents (123)
Patient recruitment (70)
Peanut (35)
People (25650)
Pharmaceutical (47)
Pharmacy benefit managers (5)
Phase I (14602)
Phase II (19261)
Phase III (12170)
Pipeline (778)
Policy (43)
Postmarket research (853)
Preclinical (6162)
Press Release (30)
Prostate cancer (57)
Psychedelics (35)
Radiopharmaceuticals (212)
Rare diseases (288)
Real estate (1421)
Recruiting (12)
Regulatory (8665)
Reports (15)
Research institute (954)
Resumes & cover letters (17)
Rett syndrome (4)
RNA editing (4)
RSV (10)
Schizophrenia (57)
Series A (95)
Series B (60)
Service/supplier (1)
Sickle cell disease (40)
Southern California (1438)
Special edition (11)
Spinal muscular atrophy (117)
Sponsored (11)
Startups (1974)
State (1)
Stomach cancer (5)
Supply chain (20)
Tariffs (5)
The Weekly (36)
United States (12775)
Vaccines (211)
Venture capitalists (30)
Weight loss (108)
Women's health (15)
Worklife (2)
Date
Today (42)
Last 7 days (264)
Last 30 days (1333)
Last 365 days (19691)
2025 (5551)
2024 (20683)
2023 (22578)
2022 (27011)
2021 (28004)
2020 (23522)
2019 (16320)
2018 (11796)
2017 (13817)
2016 (11918)
2015 (14427)
2014 (10424)
2013 (7514)
2012 (7565)
2011 (7641)
2010 (7444)
Location
Africa (149)
Alabama (41)
Alaska (2)
Arizona (53)
Arkansas (5)
Asia (17356)
Australia (2944)
California (3708)
Canada (1101)
China (341)
Colorado (143)
Connecticut (147)
Delaware (95)
Europe (37452)
Florida (446)
Georgia (116)
Idaho (16)
Illinois (220)
India (10)
Indiana (90)
Iowa (1)
Japan (73)
Kansas (61)
Kentucky (5)
Louisiana (3)
Maine (11)
Maryland (464)
Massachusetts (2929)
Michigan (70)
Minnesota (142)
Mississippi (1)
Missouri (24)
Montana (14)
Nebraska (4)
Nevada (18)
New Hampshire (14)
New Jersey (937)
New Mexico (12)
New York (1005)
North Carolina (536)
North Dakota (4)
Northern California (1634)
Ohio (111)
Oklahoma (9)
Oregon (21)
Pennsylvania (735)
Puerto Rico (5)
Rhode Island (17)
South America (208)
South Carolina (4)
Southern California (1438)
Tennessee (25)
Texas (423)
Utah (50)
Virginia (75)
Washington D.C. (30)
Washington State (338)
Wisconsin (14)
268,897 Results for "macrophage therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Drug Development
Carisma Therapeutics Presents Preclinical Proof of Concept Data Demonstrating the Anti-Fibrotic Potential of Engineered Macrophages at ASGCT 2024
Carisma Therapeutics Inc. announced new data demonstrating preclinical proof of concept using engineered anti-fibrotic macrophages for the treatment of liver fibrosis.
May 8, 2024
·
6 min read
Press Releases
Hemogenyx Pharmaceuticals PLC Announces CBR Macrophage Delivery Update
December 6, 2024
·
3 min read
Press Releases
Macrophage Marker Market Size to Hit USD 398.2 Million by 2030, Says Coherent Market Insights
January 16, 2025
·
1 min read
Drug Development
Pheast Unveils First Preclinical Data for PHST001, an Anti-CD24 Macrophage Checkpoint Inhibitor
Pheast Therapeutics today announced the first presentation of preclinical data for PHST001, an anti-CD24 antibody drug candidate that is designed to block a key macrophage “don’t eat me” signal on cancer cells.
May 13, 2024
·
2 min read
Business
Macomics and the Institute of Oncology Research (IOR, Switzerland) Announce Macrophage Scientific Collaboration in Prostate Cancer Drug Development
Macomics Ltd, a leader in macrophage drug discovery, announces that it has entered a scientific collaboration with Prof. Andrea Alimonti at IOR, one of Switzerland’s leading research institutes.
June 19, 2024
·
5 min read
Business
Macomics and IFOM (the AIRC Institute of Molecular Oncology) Announce Macrophage Scientific Collaboration
Macomics Ltd, a leader in macrophage drug discovery, announces that it has entered a scientific collaboration with Prof. Massimiliano Pagani from the IFOM, one of Italy’s leading research institutes in Cancer Research.
May 13, 2024
·
4 min read
Press Releases
Hemogenyx Pharmaceuticals PLC Announces Macrophage-Directed Therapies Summit Presentation
July 29, 2024
·
2 min read
Policy
Sobi Receives US FDA Fast Track Designation for Emapalumab-lzsg being investigated in Macrophage Activation Syndrome
Sobi North America, the North American affiliate of Swedish Orphan Biovitrum AB, announced that the US Food and Drug Administration has granted Fast Track designation to emapalumab-lzsg being investigated as a potential therapeutic option in patients with Macrophage Activation Syndrome.
May 24, 2024
·
5 min read
BioForest
Kineta to Present at the 5th Annual Macrophage-Directed Therapies Summit
Kineta, Inc. announced today that it will present at the 5th Annual Macrophage-Directed Therapies Summit, to be held on November 13-15, 2023 in Boston, MA.
November 9, 2023
·
1 min read
Press Releases
Pheast Presents New Preclinical Data for PHST001, an Anti-CD24 Macrophage Checkpoint Inhibitor, at SITC 2024
November 7, 2024
·
2 min read
1 of 26,890
Next
